In vitro synthesis of primary specific anti-breast cancer antibodies by normal human peripheral blood mononuclear cells.
Cancer Immunol. Immunother., Dec;60(12):1707-20 (2011)
Activated T cells from umbilical cord blood armed with anti-CD3 Ã? anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood transplant
Transfusion., Jan;52(1):63-75 (2012)
A Th1 cytokine-enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells.
Cancer Immunol. Immunother., Apr;61(4):497-509 (2012)
Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-Î²1 activity.
Cancer Immunol. Immunother., May;61(5):701-11 (2012)
Generation and immunologic functions of Th17 cells in malignant gliomas.
Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease.
Biol. Blood Marrow Transplant., Apr;15(4):395-405 (2009)
Role of donor lymphocyte infusions in relapsed hematological malignancies after stem cell transplantation revisited.
Cancer Treat. Rev., Nov;36(7):528-38 (2010)
Cancer therapy with bispecific antibodies: Clinical experience.
Curr. Opin. Mol. Ther., Jun;12(3):340-9 (2010)
Busulfan-based regimens and allogeneic bone marrow transplantation in patients with myelodysplastic syndromes.
Blood., Apr;81(8):2194-9 (1993)
Targeting T cells with bispecific antibodies for cancer therapy.
BioDrugs., Dec;25(6):365-79 (2011)
The immunological contribution of NF-ÎºB within the tumor microenvironment: A potential protective role of zinc as an anti-tumor agent.
Biochim. Biophys. Acta., Apr;1825(2):160-72 (2012)
Targeting cytomegalovirus-infected cells using T cells armed with anti-CD3 Ã? anti-CMV bispecific antibody.
Biol. Blood Marrow Transplant., Jul;18(7):1012-22 (2012)
Induction of specific cellular and humoral responses against renal cell carcinoma after combination therapy with cryoablation and granulocyte-macrophage colony stimulating factor: a pilot study.
J. Immunother., Jun;34(5):457-67 (2011)
Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma.
Blood., Aug;84(4):1050-5 (1994)
Graft failure in children receiving HLA-mismatched marrow transplants with busulfan-containing regimens.
Bone Marrow Transplant., Jun;13(6):817-22 (1994)
In vitro regulation of immunoglobulin synthesis after human marrow transplantation. II. Deficient T and non-T lymphocyte function within 3-4 months of allogeneic, syngeneic, or autologous marrow grafting for hematologic malignancy.
Blood., Apr;59(4):844-50 (1982)
Functional diversity in OKT4 and OKT8 subsets from long-term survivors after HLA-identical marrow grafting.
Diagn Immunol., 1(3):179-87 (1983)
The regulation of immunoglobulin synthesis after HLA-identical bone marrow transplantation: VI. Differential rates of maturation of distinct functional groups within lymphoid subpopulations in patients after human marrow grafting.
Blood., Jun;65(6):1422-33 (1985)
Immunologic recovery in human marrow graft recipients given cyclosporine or methotrexate for the prevention of graft-versus-host disease.
Transplantation., May;37(5):456-61 (1984)
Severe aplastic anemia associated with chronic mucocutaneous candidiasis. Immunologic and hematologic reconstitution after allogeneic bone marrow transplantation.
Transplantation., May;41(5):583-6 (1986)